CompaniesRondo Therapeutics
Rondo Therapeutics logo

Rondo Therapeutics

active
Hayward, CA, United States
Founded 2020
Website
About

Immuno-oncology platform for treating solid tumors, Bispecific Antibodies

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyBiotech
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

149

By Phase

PHASE1: 1

By Status

NOT_YET_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
2030
Today
NCT07218003
Hover over trial bars to see details

Recent Trials

NCT07218003Lead Sponsor
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
PHASE1Not yet recruiting
149 participants
Started: Oct 27, 2025 · Completed: Mar 31, 2029
Locations (1)
Headquarters
Hayward, CA, United States
Map

Loading map...